Core Viewpoint - Jiuan Medical's stock performance shows a mixed trend with a slight increase in share price but a significant drop in operating revenue, indicating potential challenges ahead for the company [1][2]. Financing and Trading Activity - On November 17, Jiuan Medical's stock rose by 0.62% with a trading volume of 789 million yuan. The financing buy-in amounted to 99.33 million yuan, while financing repayment was 117 million yuan, resulting in a net financing outflow of 17.46 million yuan [1]. - As of November 17, the total margin trading balance for Jiuan Medical was 1.265 billion yuan, with a financing balance of 1.254 billion yuan, representing 6.14% of the circulating market value, which is above the 90th percentile of the past year [1]. - In terms of securities lending, on November 17, 2,300 shares were repaid while 6,000 shares were sold short, with a total short sale value of 263,300 yuan. The remaining short position was 26,180 shares, with a short balance of 11.49 million yuan, also above the 90th percentile of the past year [1]. Company Financial Performance - For the period from January to September 2025, Jiuan Medical reported operating revenue of 1.069 billion yuan, a year-on-year decrease of 48.89%. However, the net profit attributable to shareholders increased by 16.11% to 158.9 million yuan [2]. - Since its A-share listing, Jiuan Medical has distributed a total of 1.794 billion yuan in dividends, with 1.39 billion yuan distributed over the past three years [3]. Shareholder Structure - As of November 10, the number of shareholders for Jiuan Medical reached 68,600, an increase of 1.63% from the previous period. The average number of circulating shares per shareholder decreased by 1.60% to 6,768 shares [2]. - Among the top ten circulating shareholders, Huabao Zhongzheng Medical ETF holds 9.4265 million shares, a decrease of 1.562 million shares from the previous period. Other notable shareholders include Southern Zhongzheng 500 ETF and Hong Kong Central Clearing Limited, both of which also saw reductions in their holdings [3].
九安医疗11月17日获融资买入9933.30万元,融资余额12.54亿元